243 related articles for article (PubMed ID: 28235545)
21. Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease.
Makovac E; Serra L; Spanò B; Giulietti G; Torso M; Cercignani M; Caltagirone C; Bozzali M
J Alzheimers Dis; 2016; 50(2):591-604. PubMed ID: 26836635
[TBL] [Abstract][Full Text] [Related]
22. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129
[TBL] [Abstract][Full Text] [Related]
23. Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
Connors MH; Ames D; Woodward M; Brodaty H
Am J Geriatr Psychiatry; 2018 Mar; 26(3):304-313. PubMed ID: 29174998
[TBL] [Abstract][Full Text] [Related]
24. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease.
Craig D; Mirakhur A; Hart DJ; McIlroy SP; Passmore AP
Am J Geriatr Psychiatry; 2005 Jun; 13(6):460-8. PubMed ID: 15956265
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with psychotic symptoms in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Hashimoto M; Yamashita H
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):648-52. PubMed ID: 9598682
[TBL] [Abstract][Full Text] [Related]
26. A Multimodal Neuroimaging and Neuropsychological Study of Visual Hallucinations in Alzheimer's Disease.
Pezzoli S; Manca R; Cagnin A; Venneri A;
J Alzheimers Dis; 2022; 89(1):133-149. PubMed ID: 35848016
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease.
Mackin RS; Insel P; Zhang J; Mohlenhoff B; Galasko D; Weiner M; Mattsson N
J Alzheimers Dis; 2015; 43(3):1007-16. PubMed ID: 25125463
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
29. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
Christie D; Shofer J; Millard SP; Li E; Demichele-Sweet MA; Weamer EA; Kamboh MI; Lopez OL; Sweet RA; Tsuang D
Behav Brain Funct; 2012 Dec; 8():62. PubMed ID: 23270420
[TBL] [Abstract][Full Text] [Related]
30. Psychosis and physical aggression in probable Alzheimer's disease.
Deutsch LH; Bylsma FW; Rovner BW; Steele C; Folstein MF
Am J Psychiatry; 1991 Sep; 148(9):1159-63. PubMed ID: 1882992
[TBL] [Abstract][Full Text] [Related]
31. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
Canevelli M; Adali N; Cantet C; Andrieu S; Bruno G; Cesari M; Vellas B;
J Neurol; 2013 Jul; 260(7):1859-65. PubMed ID: 23504051
[TBL] [Abstract][Full Text] [Related]
32. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.
Lyketsos CG; Baker L; Warren A; Steele C; Brandt J; Steinberg M; Kopunek S; Baker A
J Neuropsychiatry Clin Neurosci; 1997; 9(1):64-7. PubMed ID: 9017530
[TBL] [Abstract][Full Text] [Related]
33. Incidence of and risk factors for hallucinations and delusions in patients with probable AD.
Paulsen JS; Salmon DP; Thal LJ; Romero R; Weisstein-Jenkins C; Galasko D; Hofstetter CR; Thomas R; Grant I; Jeste DV
Neurology; 2000 May; 54(10):1965-71. PubMed ID: 10822438
[TBL] [Abstract][Full Text] [Related]
34. Hallucinations, cognitive decline, and death in Alzheimer's disease.
Wilson RS; Tang Y; Aggarwal NT; Gilley DW; McCann JJ; Bienias JL; Evans DA
Neuroepidemiology; 2006; 26(2):68-75. PubMed ID: 16352909
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.
Ropacki SA; Jeste DV
Am J Psychiatry; 2005 Nov; 162(11):2022-30. PubMed ID: 16263838
[TBL] [Abstract][Full Text] [Related]
36. [Psychiatric, psychological comorbidities of typical and atypical Charles-Bonnet syndrome].
Bou Khalil R; Richa S
Encephale; 2011 Dec; 37(6):473-80. PubMed ID: 22137220
[TBL] [Abstract][Full Text] [Related]
37. On hallucinations and memory: the relationship between hallucinations and autobiographical overgenerality in Alzheimer's Disease.
El Haj M; Larøi F
Acta Neuropsychiatr; 2024 Jun; 36(3):162-166. PubMed ID: 38369926
[TBL] [Abstract][Full Text] [Related]
38. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
[TBL] [Abstract][Full Text] [Related]
39. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
[TBL] [Abstract][Full Text] [Related]
40. Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception.
Burns A; Jacoby R; Levy R
Br J Psychiatry; 1990 Jul; 157():76-81, 92-4. PubMed ID: 2397366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
